Latest 10-K annual reports

Integrated Wellness Acquisition Corp's 10-K filing reveals ongoing efforts to complete a business combination with Btab Ecommerce Group, challenges with NYSE delisting, and financial uncertainties impacting its ability to continue as a going concern.
AMEX
Air Industries Group saw a revenue increase and backlog growth in 2024, but still reported a net loss, according to its latest 10-K filing.
NASDAQ
TSS, Inc. announces a significant increase in revenue and a return to profitability in its 2024 10-K filing, driven by growth in AI-enabled rack integration and procurement services.
Shorepower Technologies saw a significant revenue increase in 2024, but net losses persist as the company focuses on expanding its electric vehicle charging infrastructure.
NASDAQ
Princeton Bancorp files an amendment to its annual report on Form 10-K to include previously omitted exhibits and to amend employment agreements with key executives.
OQB
Vycor Medical's 2024 10-K filing reveals a revenue increase driven by US sales, but also highlights concerns about the company's ability to continue as a going concern due to accumulated losses and working capital deficiency.
OTC.Pink
Sigyn Therapeutics' 2024 annual report details the company's ongoing development of medical devices for cancer and infectious disease, including its lead candidate, Sigyn TherapyTM, and its efforts to secure additional capital.
OQB
QuoteMedia's 2024 annual report reveals a slight revenue decrease but outlines plans for product expansion and infrastructure upgrades in 2025.
NASDAQ
Dominari Holdings Inc. reports its 2024 annual results, highlighting a shift in focus towards financial services and strategic initiatives in the AI and data center sectors.
OID
Eline Entertainment Group's 10-K filing reveals ongoing losses and a search for a merger or acquisition target, raising concerns about the company's ability to continue as a going concern.
Cluster Group Holdings Limited Co. (CLUS) files its annual report on Form 10-K, detailing its plans to pursue a merger or acquisition in the food industry and reporting a net loss of $58,459 for the year ended December 31, 2024.
OTC.Pink
Spindletop Oil & Gas Co.'s 2024 10-K filing reveals a decrease in oil and gas revenues amid fluctuating commodity prices, while the company continues to explore strategic alternatives to enhance shareholder value.
OTC.Pink
Bravo Multinational Inc.'s FY 2024 results reveal no revenue, a net loss, and substantial doubt about its ability to continue as a going concern.
OTC.Pink
Zhen Ding Resources Inc.'s 10-K filing reveals continued efforts to secure financing and resume mining operations at its Chinese joint venture, while facing ongoing financial challenges.
OTC.Pink
Clean Vision Corporation reports its fiscal year 2024 results, highlighting its focus on clean technology and sustainability opportunities within the clean energy and waste-to-value industries.
OTC.Pink
Byrn Inc., a dormant shell company, filed its annual report on Form 10-K, outlining its current state and future plans to explore potential business opportunities.
OID
SEATech Ventures Corp. reported no revenue for the fiscal year ended December 31, 2024, citing adverse economic conditions and a cancelled acquisition, while also disclosing material weaknesses in internal controls.
NASDAQ
BioNexus Gene Lab Corp. announces its fiscal year 2024 results, highlighting a strong liquidity position, strategic innovation initiatives, and proactive governance enhancements while addressing Nasdaq compliance challenges.
Lucent Inc.'s latest filing reveals a $95.2 million asset valuation as of December 31, 2024, primarily attributed to the mineral resource potential of its gold and graphite mining projects in Mexico.
OTC.Pink
Vanjia Corporation's 2024 10-K filing reveals a net loss but outlines plans for affordable housing development in Houston, supported by a director's line of credit.
OTC.Pink
Baltic International USA, Inc. files its annual report on Form 10-K, highlighting its ongoing efforts to identify and acquire a target company while navigating minimal assets and a history of operating losses.
AMEX
Hyperscale Data, Inc. files its 10-K report for fiscal year 2024, detailing financial results and a strategic pivot from Bitcoin mining to AI and high-performance computing.
NASDAQ
BranchOut Food Inc.'s 2024 annual report reveals a year of strategic expansion, including the launch of a new production facility in Peru, alongside ongoing financial challenges and a net loss of $4.75 million.
NASDAQ
SS Innovations International's 2024 10-K filing reveals a significant revenue increase driven by surgical robotic system sales, but also highlights substantial doubt about the company's ability to continue as a going concern due to recurring losses and dependence on external funding.
NASDAQ
MediaCo Holding Inc.'s 2024 10-K filing highlights the impact of the Estrella Acquisition on revenue growth and strategic focus on multicultural audiences.
NYSE
Constellium SE files an amendment to its 2024 Annual Report on Form 10-K, updating information on executive compensation, security ownership, and the equity incentive plan.
OTC.Pink
GeoSolar Technologies, still in its development stage, reports a net loss of $1.54 million for 2024 while initiating revenue generation through its SmartGreen Home system.
OTC.Pink
New Momentum Corporation's 10-K filing reveals a net loss for 2024 and expresses substantial doubt about the company's ability to continue as a going concern.
Adverum Biotechnologies' 10-K filing reveals substantial doubt about its ability to continue as a going concern due to recurring losses, a material weakness in internal controls, and the need for additional funding.
NASDAQ
Spruce Biosciences reports significant net losses and raises substantial doubt about its ability to continue as a going concern despite advancements in its clinical development programs.